인쇄하기
취소

Revised Guidelines on BSE Will Become Effective Next April

Published: 2004-12-29 06:56:00
Updated: 2004-12-29 06:56:00
The Korea Food and Drug Administration (KFDA) announced on December 28th of its revised guidelines addressed to the pharmaceutical manufacturers and importers handling bovine-derived materials intended for human use, to further strengthen the safety measures for Bovine Spongiform Encephalopathy (BSE), also known as mad cow disease.

The KFDA stated that the revised guidelines will fully be ef...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.